Filing Details
- Accession Number:
- 0001654954-24-007748
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-13 18:32:05
- Reporting Period:
- 2024-06-12
- Accepted Time:
- 2024-06-13 18:32:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1684144 | Zomedica Corp. | ZOM | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1999774 | Kevin Russell Klass | C/O Zomedica Corp. 100 Phoenix Drive, Suite 125 Ann Arbor MI 48108 | Vice President Of Sales | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Without Par Value | Acquisiton | 2024-06-12 | 299,993 | $0.16 | 2,000,050 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported is the weighted average price. These shares were sold in multiple transactions ranging from $0.1520 to $0.1559, inclusive. The reporting person undertakes to provide to Zomedica Corp., any security holder of Zomedica Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.
Billionaire Hedge Funds
